| DC Field | Value | Language |
|---|
| dc.contributor.author | Kononova, S. | - |
| dc.contributor.author | Mal, G. | - |
| dc.contributor.author | Azarova, I. | - |
| dc.contributor.author | Klyosova, E. | - |
| dc.contributor.author | Bykanova, M. | - |
| dc.contributor.author | Churnosov, M. | - |
| dc.contributor.author | Polonikov, A. | - |
| dc.date.accessioned | 2023-07-04T07:38:54Z | - |
| dc.date.available | 2023-07-04T07:38:54Z | - |
| dc.date.issued | 2022 | - |
| dc.identifier.citation | Pharmacogenetic loci for rosuvastatin are associated with intima-media thickness change and coronary artery disease risk / S. Kononova [et al.] // Pharmacogenomics. - 2022. - Vol.23, №1.-P. 15-34. - Doi: 10.2217/pgs-2021-0097. | ru |
| dc.identifier.uri | http://dspace.bsu.edu.ru/handle/123456789/54594 | - |
| dc.description.abstract | The present study investigated whether polymorphisms at these genes are associated with the risk of coronary artery disease (CAD) development, and reduction of atherogenic lipids and carotid intima-media thickness (CIMT) in CAD patients, taking rosuvastatin | ru |
| dc.language.iso | en | ru |
| dc.subject | medicine | ru |
| dc.subject | internal illnesses | ru |
| dc.subject | carotid intima-media thickness | ru |
| dc.subject | coronary artery disease | ru |
| dc.subject | pharmacology | ru |
| dc.subject | pharmacogenetics | ru |
| dc.subject | polymorphism | ru |
| dc.subject | lipids | ru |
| dc.subject | risks | ru |
| dc.subject | rosuvastatin | ru |
| dc.title | Pharmacogenetic loci for rosuvastatin are associated with intima-media thickness change and coronary artery disease risk | ru |
| dc.type | Article | ru |
| Appears in Collections: | Статьи из периодических изданий и сборников (на иностранных языках) = Articles from periodicals and collections (in foreign languages)
|
